Founded in July 2020, Westlake Omics is an AI-empowered micro-world data company. Westlake Omics aims to boost precision medicine and drug research and development by integrating technological innovations in proteomics and big multimodal data. Westlake Omics has now more than 100 highly-qualified talents with diverse backgrounds such as biology, medicine, and AI.
Westlake Omics has established cooperation with over 100 renowned universities and research institutes, hospitals, and pharmaceutical companies from home and abroad and is the owner of several national patents and computer software copyrights.
Tenured Associate Professor, Westlake University
Director, Center for Intelligent Proteomics, Westlake Laboratory
Founder, Westlake Omics
More in www.guomics.com and www.imarkerlab.com.
Prof. Mark S. Baker, PhD
Honorary Professor @ Macquarie Medical School, Macquarie University;
Co-Principle Investigator and Scientific Steering Committee Member π-HuB (Proteomic Navigator of the Human Body Project);
Previous CEO and Director, Australian Proteome Analysis Facility;
Past President, Human Proteome Organization (HUPO);
Past Chair, global Human Proteome Project (HUPO HPP).
Dr. Luonan Chen
Researcher at Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; Principal Professor at Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences; Executive Director of Key Laboratory of Systems Biology, Chinese Academy of Sciences
Dr. Zhongzhi Luan
The deputy dean of the China-Germany Joint Software Institute of School of Computer Science and Engineering at Beihang University.
Dr. Changzheng Yuan
Research Professor and Doctoral supervisor at Zhejiang University School of Public Health
Ju-Sheng Zheng, Ph.D.
Principal Investigator, Assistant Professor and PhD supervisor